AOD-9604 is a modified fragment of human growth hormone comprising residues 176–191 of the hGH C-terminus, engineered to isolate the lipolytic activity of the parent molecule while eliminating its growth-promoting and diabetogenic effects. This fragment retains the ability to stimulate lipolysis and inhibit lipogenesis through direct interaction with fat cell beta-adrenergic receptors and downstream cAMP signaling pathways, without activating the IGF-1 axis — a critical research distinction for metabolic studies requiring fat-specific mechanistic data.
AOD-9604 has been studied in preclinical and clinical research for its effects on adipose tissue reduction, metabolic rate enhancement, and cartilage/bone repair via TGF-beta pathway modulation, with its favorable safety profile and regulatory history making it a well-characterized compound for body composition and regenerative research.
Specifications:
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Storage: −20°C
For Research Use Only.









Reviews
There are no reviews yet.